Moderna stock tumbled again Friday on a series of downgrades and price-target cuts following a "tough update" at its R&D Day.

As of 12 September at 15:49 GMT-4. Market open. Adjusted closing price adjusted for splits and dividend and/or capital gain distributions.

By Dr. Chinta Sidharthan New study uncovers a higher prevalence of heart scarring in young males after COVID-19 mRNA ...

I am deeply troubled by the growing distrust of science in our society, just at the time when its insights are most needed.

Pfizer and Moderna mRNA vaccines are updated to better match currently circulating COVID strains, while the Novavax adjuvant ...

Covid-19 vaccines are available across the United States. Vaccines represent the best protection against sever illness and ...

With donor livers in short supply, they think mRNA could one day provide an alternative to transplants. The team plans to begin a clinical trial next year to test the idea in people with end-stage ...

A German study published in July 2024 did not find that mRNA COVID-19 vaccines damaged children’s immune systems, contrary to posts shared online suggesting the study found signs of an immune ...

20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have ...

Present Market Standing of Moderna Trading volume stands at 5,013,059, with MRNA's price down by -2.52%, positioned at $68.1. RSI indicators show the stock to be may be approaching oversold. Earnings ...

Delving into the details, we found 45% of traders were bullish, while 36% showed bearish tendencies. Out of all the trades we ...